- Institut de Recerca Biomèdica de Lleida (IRB-Lleida)
Institut d'investigació
![Foto de - Institut de Recerca Biomèdica de Lleida (IRB-Lleida)](/img/noimage.png)
![Foto de Complexo Hospitalario Universitario de Pontevedra](/img/noimage_org.png)
Complexo Hospitalario Universitario de Pontevedra
Pontevedra, EspañaPublikationen in Zusammenarbeit mit Forschern von Complexo Hospitalario Universitario de Pontevedra (12)
2023
-
Assessment of obesity stigma and discrimination among Spanish subjects with a wide weight range: the OBESTIGMA study
Frontiers in Psychology, Vol. 14
-
Detecting disability using self-reported and clinical assessments in early-stage relapsing-remitting multiple sclerosis: Looking for a complementary approach
Multiple Sclerosis Journal - Experimental, Translational and Clinical, Vol. 9, Núm. 2
-
Hopelessness in Patients with Early-Stage Relapsing-Remitting Multiple Sclerosis
Patient Preference and Adherence, Vol. 17, pp. 1431-1439
2022
-
Delayed cognitive processing and treatment status quo bias in early-stage multiple sclerosis
Multiple Sclerosis and Related Disorders, Vol. 68
-
Long-term prognosis communication preferences in early-stage relapsing-remitting multiple sclerosis
Multiple Sclerosis and Related Disorders, Vol. 64
-
Measuring productivity loss in early relapsing-remitting multiple sclerosis
Multiple Sclerosis and Related Disorders, Vol. 58
2018
-
Interindividual differences in the clinical effectiveness of liraglutide in Type 2 diabetes: a real-world retrospective study conducted in Spain
Diabetic Medicine, Vol. 35, Núm. 11, pp. 1605-1612
2017
-
Peculiarities of the obese patient with cancer: a national consensus statement by the Spanish Society for the Study of Obesity and the Spanish Society of Medical Oncology
Clinical and Translational Oncology, Vol. 19, Núm. 6, pp. 682-694
2015
-
Obesity as a risk factor in cancer: A national consensus of the Spanish Society for the Study of Obesity and the Spanish Society of Medical Oncology
Clinical and Translational Oncology, Vol. 17, Núm. 10, pp. 763-771
2014
-
Long-term effectiveness of glatiramer acetate in clinical practice conditions
Journal of Clinical Neuroscience, Vol. 21, Núm. 12, pp. 2212-2218
2012
-
Impact of apathy on health-related quality of life in recently diagnosed Parkinson's disease: The ANIMO study
Movement Disorders, Vol. 27, Núm. 2, pp. 211-218
2010
-
Cetuximab given every 2 weeks plus irinotecan is an active and safe option for previously treated patients with metastatic colorectal cancer
Chemotherapy, Vol. 56, Núm. 2, pp. 142-146